University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 3C-07-5


 
Description: A Blinded, Randomized, Phase I/II Study of Brivanib Alaninate vs. Placebo in Combination with Erbitux and Irinotecan in K-Ras Wild Type Subjects with Metastatic Colorectal Cancer.
Status: Open
Randomized? Yes


Researchers  
Principal InvestigatorTitle
Anthony El-KhoueiryM.D.

Data Management
NameTitle
jiayi jiangD.M.
Susan EdwardsR.N.
Xiomara MenendezR.N.
San AyeD.M.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.